PLS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.328300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.450210E-01
Normal-vs-Stage2
6.165800E-02
Normal-vs-Stage3
3.527000E-01
Normal-vs-Stage4
1.082840E-01
Stage1-vs-Stage2
7.091400E-01
Stage1-vs-Stage3
7.506400E-01
Stage1-vs-Stage4
3.300400E-01
Stage2-vs-Stage3
7.953400E-01
Stage2-vs-Stage4
3.096800E-01
Stage3-vs-Stage4
3.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.451800E-02
Normal-vs-AfricanAmerican
1.399430E-01
Normal-vs-Asian
6.793800E-02
Caucasian-vs-AfricanAmerican
1.244770E-01
Caucasian-vs-Asian
2.116400E-01
AfricanAmerican-vs-Asian
6.985200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.059900E-02
Normal-vs-Female
9.734400E-02
Male-vs-Female
8.789400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.949200E-01
Normal-vs-Age(41-60Yrs)
8.233500E-02
Normal-vs-Age(61-80Yrs)
8.250000E-02
Normal-vs-Age(81-100Yrs)
1.302440E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.046600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.707200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.864800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.303770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.555400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.541800E-02
Normal-vs-Daily Drinker
1.842810E-01
Normal-vs-Weekly Drinker
2.003000E-01
Normal-vs-Occasional Drinker
4.340500E-02
Normal-vs-Social Drinker
1.039840E-01
Non Drinker-vs-Daily Drinker
5.173000E-01
Non Drinker-vs-Weekly Drinker
3.572000E-01
Non Drinker-vs-Occasional Drinker
4.396200E-01
Non Drinker-vs-Social Drinker
3.490800E-01
Daily Drinker-vs-Weekly Drinker
7.579600E-01
Daily Drinker-vs-Occasional Drinker
2.049400E-01
Daily Drinker-vs-Social Drinker
7.816800E-01
Weekly Drinker-vs-Occasional Drinker
1.350440E-01
Weekly Drinker-vs-Social Drinker
9.512400E-01
Occasional Drinker-vs-Social Drinker
1.102650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.5823999999508E-06
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.468190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.279700E-02
Grade 1-vs-Grade 3
7.152300E-02
Grade 1-vs-Grade 4
2.5823999999508E-06
Grade 2-vs-Grade 3
5.396000E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.468190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.033800E-01
Normal-vs-NonDiabetic
5.265700E-02
Diabetic-vs-NonDiabetic
7.982400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.153900E-02
Normal-vs-NoPancreatitis
8.462100E-02
Pancreatitis-vs-NoPancreatitis
8.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.059850E-01
Normal-vs-N1
7.242200E-02
N0-vs-N1
8.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.991700E-02
Normal-vs-TP53-NonMutant
1.219800E-01
TP53-Mutant-vs-TP53-NonMutant
4.116600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
